封面
市场调查报告书
商品编码
1691710

马匹医疗保健市场 - 全球产业规模、份额、趋势、机会和预测,按产品、适应症、活动、配销通路、地区和竞争细分,2020-2030 年

Equine Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Activity, By Distribution Channel, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球马匹医疗保健市场价值为 35.8 亿美元,预计到 2030 年将达到 57.7 亿美元,复合年增长率为 8.26%。随着人们对马匹健康管理认识的提高和对兽医护理的投资增加,全球马匹医疗保健市场正在稳步增长。随着马主、饲养者和马术专业人士越来越重视动物福利,对预防性医疗保健解决方案(包括疫苗、驱虫药和先进的诊断工具)的需求也日益增加。越来越多地采用技术先进的监测设备和可穿戴感测器进行即时健康状况跟踪,改变了马匹的医疗保健实践。该行业也见证了专门的马匹保险政策的激增,使得先进的治疗变得更加容易获得。马匹復健中心和再生医学疗法(如干细胞和富血小板血浆治疗)的出现进一步促进了市场扩张。

市场概况
预测期 2026-2030
2024 年市场规模 35.8 亿美元
2030 年市场规模 57.7 亿美元
2025-2030 年复合年增长率 8.26%
成长最快的领域 诊断
最大的市场 北美洲

推动市场发展的是针对马科动物的兽药、营养和疾病管理解决方案的进步。马疾病(包括呼吸道疾病、蹄叶炎和传染病)的发生率日益上升,推动了对创新治疗方案的需求。越来越多的人参与马术运动和比赛,这也推动了对錶现监测、伤害预防和骨科护理的需求。远距医疗和基于人工智慧的诊断平台等数位健康解决方案的采用正在提高兽医咨询和治疗效率。政府支持马病控制和生物安全措施的措施也在市场成长中发挥至关重要的作用。

该行业面临的挑战与先进的马匹医疗费用高昂以及偏远地区获得专门兽医护理的机会有限有关。有关马药审批和动物福利政策的严格规定影响了新保健产品的商业化。对假兽药的担忧以及提高诊断准确性的需求带来了额外的障碍。控制马群中的传染病爆发仍然是一个关键问题,需要加强生物安全措施和疫苗接种计划。该市场为个人化马匹营养、穿戴式健康监测设备和再生疗法的创新提供了机会,预计将推动长期成长。

主要市场驱动因素

马术运动和活动的参与度不断提高

主要市场挑战

专科护理费用高昂

主要市场趋势

精准医疗和个人化护理

目录

第 1 章:产品概述

第 2 章:研究方法

第 3 章:执行摘要

第 4 章:顾客之声

第五章:全球马匹保健市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品(疫苗、药品、药用饲料添加剂、诊断、软体和服务、其他)
    • 依适应症分类(肌肉骨骼疾病、寄生虫控制、内科、马疱疹病毒、马脑​​脊髓炎、马流感、西尼罗河病毒、破伤风、其他)
    • 按活动(运动/赛车、娱乐、其他)
    • 依配销通路(兽医院及诊所、电子商务、其他)
    • 按公司分类(2024)
    • 按地区
  • 市场地图

第六章:北美马匹保健市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 墨西哥
    • 加拿大

第七章:欧洲马匹保健市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章:亚太马匹保健市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章:南美洲马匹保健市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章:中东和非洲马匹保健市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 合併与收购(如有)
  • 产品发布(如果有)
  • 最新动态

第 13 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章:竞争格局

  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Hallmarq Veterinary Imaging Ltd
  • Esaote SpA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Arthrex Inc.
  • Heska Corporation

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 17486

Global Equine Healthcare Market was valued at USD 3.58 Billion in 2024 and is expected to reach USD 5.77 Billion in the forecast period with a CAGR of 8.26% through 2030. The Global Equine Healthcare Market is experiencing steady growth due to rising awareness about equine health management and increasing investments in veterinary care. The demand for preventive healthcare solutions, including vaccines, dewormers, and advanced diagnostic tools, is expanding as horse owners, breeders, and equestrian professionals prioritize animal welfare. The growing adoption of technologically advanced monitoring devices and wearable sensors for real-time health tracking has transformed equine healthcare practices. The industry is also witnessing a surge in specialized equine insurance policies, making advanced treatments more accessible. The emergence of equine rehabilitation centers and regenerative medicine therapies such as stem cell and platelet-rich plasma treatments is further contributing to market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.58 Billion
Market Size 2030USD 5.77 Billion
CAGR 2025-20308.26%
Fastest Growing SegmentDiagnostics
Largest MarketNorth America

The market is driven by advancements in veterinary pharmaceuticals, nutrition, and disease management solutions tailored for equine species. The increasing prevalence of equine diseases, including respiratory disorders, laminitis, and infectious conditions, is pushing the demand for innovative treatment options. Rising participation in equestrian sports and racing is fueling the need for performance monitoring, injury prevention, and orthopedic care. The adoption of digital health solutions, such as telemedicine and AI-based diagnostic platforms, is enhancing veterinary consultations and treatment efficiency. Government initiatives supporting equine disease control and biosecurity measures are also playing a crucial role in market growth.

The industry faces challenges related to the high costs associated with advanced equine medical treatments and limited access to specialized veterinary care in remote areas. Stringent regulations governing equine drug approvals and animal welfare policies impact the commercialization of new healthcare products. Concerns over counterfeit veterinary drugs and the need for improved diagnostic accuracy pose additional hurdles. Managing infectious disease outbreaks in equine populations remains a critical issue, requiring enhanced biosecurity measures and vaccination programs. The market presents opportunities for innovation in personalized equine nutrition, wearable health monitoring devices, and regenerative therapies, which are expected to drive long-term growth.

Key Market Drivers

Rising Participation in Equestrian Sports and Activities

Equestrian sports and activities have a rich history that spans centuries, from the historic races of ancient Greece to the modern arenas of Olympic dressage. What was once a niche interest has now evolved into a global phenomenon, with millions of enthusiasts participating in various equestrian disciplines. This surge in equestrian engagement is not only shaping the sports landscape but also driving the growth of the global equine healthcare market.

As equestrian sports gain prominence, more people are investing in horse ownership. In the United States alone, the horse population was reported to be over 10.6 million in both 2020 and 2021, accounting for 18% of the world's equine population. Whether for competitive riding, leisure, or companionship, this rise in horse ownership creates a significant demand for equine healthcare services and products. Horse owners, recognizing the need to ensure the health and well-being of their equine partners, are fueling the growth of the equine healthcare market.

The growing equestrian community has fostered increased awareness of equine health and the importance of preventative measures. Horse owners, riders, and trainers understand that regular veterinary check-ups, vaccinations, and proper nutrition are essential to keeping their horses in peak condition. This heightened awareness drives the demand for equine healthcare solutions and encourages a proactive approach to horse care.

Key Market Challenges

High Cost of Specialized Care

The high cost of specialized care presents a significant challenge in the global equine healthcare market. Horses require extensive medical attention, including routine check-ups, vaccinations, dental care, and emergency treatments. When specialized care such as orthopedic surgeries, regenerative therapies, or advanced diagnostic imaging is needed, expenses rise considerably. Veterinary specialists trained in equine medicine often charge premium fees due to the complexity of procedures and the need for specialized equipment. Many horse owners struggle with these costs, especially those involved in non-commercial horse ownership or small-scale equestrian businesses.

Equine healthcare is further complicated by the need for ongoing treatments. Chronic conditions such as musculoskeletal disorders, respiratory issues, and metabolic diseases require long-term management, which leads to continuous financial burdens. Advanced treatments like stem cell therapy, laser therapy, and MRI scans can be prohibitively expensive, limiting access to necessary medical interventions. Insurance coverage for equine healthcare is not as widely available or comprehensive as human health insurance, making it difficult for owners to afford specialized care without significant out-of-pocket expenses.

The rising cost of equine healthcare has also impacted equestrian sports and breeding programs. Competitive horses require top-tier medical care to maintain performance and prevent injuries. When specialized care becomes unaffordable, it leads to compromised treatment quality, potential neglect, or premature retirement of horses from competitions. In breeding programs, high veterinary costs affect reproductive health management, including artificial insemination and embryo transfer services. Without affordable specialized care, the long-term sustainability of horse ownership and equine-related industries remains a challenge. Addressing these cost concerns through innovative financing options, insurance expansion, and technological advancements in affordable treatments is crucial for supporting the growth of the equine healthcare market.

Key Market Trends

Precision Medicine and Personalized Care

The global equine healthcare market is witnessing a shift toward precision medicine and personalized care, driven by advancements in veterinary diagnostics, genomics, and data-driven treatment approaches. Precision medicine focuses on tailoring healthcare solutions based on the specific genetic, physiological, and environmental factors of each horse. Veterinarians are leveraging genomic testing and biomarker analysis to develop individualized treatment plans, ensuring more effective disease management and preventive care. Genetic profiling enables early detection of predispositions to conditions such as laminitis, musculoskeletal disorders, and respiratory diseases, allowing for targeted interventions before clinical symptoms emerge. Personalized nutrition plans, based on metabolic profiling, are helping optimize horse health, performance, and longevity.

Wearable health-monitoring devices and telemedicine solutions are enhancing personalized care by continuously tracking vital parameters, including heart rate, temperature, and gait patterns. These real-time insights allow early detection of health abnormalities, reducing the risk of severe illnesses and costly medical interventions. Equine athletes benefit from customized rehabilitation programs, integrating physiotherapy, regenerative medicine, and laser therapy tailored to their specific recovery needs. The adoption of stem cell and gene therapy is further revolutionizing treatment strategies by offering regenerative solutions customized to the genetic makeup and condition of individual horses.

Key Market Players

  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Hallmarq Veterinary Imaging Ltd
  • Esaote SpA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Arthrex Inc.
  • Heska Corporation

Report Scope:

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product:

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

Equine Healthcare Market, By Indication:

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

Equine Healthcare Market, By Activity:

  • Sports/Racing
  • Recreation
  • Others

Equine Healthcare Market, By Distribution Channel:

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Equine Healthcare Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

Global Equine Healthcare market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 5.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Equine Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By Activity
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Equine Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Activity
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Mexico Equine Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Activity
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Canada Equine Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Activity
        • 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By Activity
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Equine Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Activity
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Equine Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Activity
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Equine Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Activity
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Equine Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Activity
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Equine Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Activity
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Equine Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By Activity
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Equine Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Activity
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Equine Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Activity
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. South Korea Equine Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Activity
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Japan Equine Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Activity
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Equine Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Activity
        • 8.3.5.2.4. By Distribution Channel

9. South America Equine Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By Activity
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Equine Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Activity
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Equine Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Activity
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Equine Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Activity
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Equine Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By Activity
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Equine Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Activity
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Equine Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Activity
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Equine Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Activity
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Zoetis Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Boehringer Ingelheim GmbH
  • 14.3. Merck & Co., Inc.
  • 14.4. Hallmarq Veterinary Imaging Ltd
  • 14.5. Esaote SpA
  • 14.6. Vetoquinol SA
  • 14.7. IDEXX Laboratories, Inc.
  • 14.8. Dechra Pharmaceuticals PLC
  • 14.9. Arthrex Inc.
  • 14.10. Heska Corporation

15. Strategic Recommendations

16. About Us & Disclaimer